Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 10, 2016 8:50 AM ET

Capital Markets

Company Overview of Brandon Capital Partners

Company Overview

Brandon Capital Partners is a venture capital firm specializing in seed stage, startup, growth capital, early venture, and mid venture investments. It prefers to invest in the life sciences, biotech, new drug discovery, and medical devices sectors. It invests in firms based in Australia. The firm seeks to invest between $160,000 and $40.38 million. Brandon Capital Partners was founded in 1999 and is based in Sydney, Australia with an additional office in Melbourne, Australia.

Level 7

210 George Street

Sydney, NSW 2010


Founded in 1999


61 2 9247 2577


61 2 9247 7344

Key Executives for Brandon Capital Partners

Founding Partner, Managing Director, Director, and Partner
Managing Director, Founding Partner, and Principal Executive of MRCF
Age: 40
Chief Financial Officer
Investment Manager
Compensation as of Fiscal Year 2015.

Brandon Capital Partners Key Developments

Brandon Capital Partners Opens San Francisco Bay Area Office

Brandon Capital Partners has expanded its operations into the United States with the opening of a San Francisco Bay Area office.

Brandon Capital Partners Presents at Bio-Trinity, May-11-2015

Brandon Capital Partners Presents at Bio-Trinity, May-11-2015 . Venue: Novotel London West, 1 Shortlands, London W6 8DR, United Kingdom.

Brandon Capital Closes an AUD 200 Million Life Science Venture Capital Fund for Medical Research Commercialization Fund

Brandon Capital announced that it has closed an AUD 200 million life science venture capital fund for the Medical Research Commercialization Fund (MRCF). Around AUD 50 million of the new fund will be reserved for 20-30 very early seed stage investments in promising biotech or medical device technologies. The remaining AUD 150 million will be reserved for supporting the most successful of these and existing MRCF portfolio companies to take these opportunities through to mid-stage clinical trials in patients. Finally, under the new fund structure, each of the superannuation investors have the opportunity to invest much larger amounts of capital (tens of millions) into the most promising assets as they mature.

Similar Private Companies By Industry

Company Name Region
Mccowan Family Trust Asia
Alert Trader Group Asia
Fortnum Financial Group Pty Ltd. Asia
FSS Advisory Pty Ltd Asia
CLEAR Commodities Pty. Ltd Asia

Recent Private Companies Transactions

Private Placement
January 6, 2016
Elastagen Pty Ltd.
Private Placement
November 23, 2015
Aravax Pty Ltd
Private Placement
November 23, 2015
Cardiora Pty Ltd

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Brandon Capital Partners, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at